Asieris Pharmaceuticals
Pharmaceutical Manufacturing • 
Radnor, Pennsylvania, United States • 51-100 Employees
Company overview
| Headquarters | 201 King of Prussia Rd., Suite 650, Radnor, Pennsylvania 19087, US |
| Phone number | +120142024 |
| Websites | |
| NAICS | 3254 |
| SIC | 283 |
| Founded | 2010 |
| Employees | 51-100 |
| Socials |
Key Contacts at Asieris Pharmaceuticals
Cike Peng
Associate Director Business Development
Hang Sai
Associated Medical Director
Koorosh Ashrafi
Senior Director Business Development
Steven Zhang
Director,Communications And Public Affairs
Michael Yang
Secretary Board Of Directors
Xinming Jiang
Vp Of Sales & Marketing
Kevin Pan
Founder, President And Ceo
Jason Tao
R&D Director_Medical Device
Amy Wang
Senior Director Clinical Development
Asieris Pharmaceuticals Email Formats
Asieris Pharmaceuticals uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@asieris.com), used 40% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@asieris.com | 40% |
{first initial}{last name} | jdoe@asieris.com | 30% |
{first name}.{last name} | john.doe@asieris.com | 30% |
About Asieris Pharmaceuticals
Asieris Pharmaceuticals, founded in March 2010, is a global innovative pharma company specializing in new drugs for the treatment of genitourinary tumors and other major diseases. We strive to improve human health and help people live a more dignified life. We aim to become a global pharma leader that integrates R&D, manufacturing and commercialization in our areas of focus, as we provide best-in-class integrated diagnosis and treatment solutions for patients in China and worldwide. The company has been developing its proprietary R&D platform and core technologies, exploring new mechanisms of action, and efficiently screening and evaluating drug candidates. With a well-established in-house R&D system and expertise in global drug development, Asieris is committed to launching first-in-class drugs and other innovative products to address huge unmet needs in its areas of focus. Asieris is also enhancing its pipeline for genitourinary diseases via proprietary R&D and strategic partnerships, while closely following cutting-edge technologies and therapeutics. The company strives to discover and identify unmet clinical needs, and adopts a forward-looking approach in product planning and life-cycle management. We aim to establish an outstanding portfolio that covers diagnosis and treatment in a bid to benefit more patients in China and globally.
Asieris Pharmaceuticals revenue & valuation
| Annual revenue | $5,047,745 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $16,200,000 |
| Total funding | $105,600,000 |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Asieris Pharmaceuticals has 26 employees across 10 departments.
Departments
Number of employees
Funding Data
Explore Asieris Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.
Asieris Pharmaceuticals Tech Stack
Discover the technologies and tools that power Asieris Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.
Analytics
JavaScript libraries
JavaScript libraries
WordPress themes
Page builders
JavaScript libraries
Font scripts
JavaScript libraries
Web servers
Miscellaneous
Security
Saudi Arabia
Netherlands
Israel
Iceland
Frequently asked questions
4.8
40,000 users
